Rosuvastatin (5mg，10mg，20mg)
CJFH-20150203-CAP
Approved small_molecule active
Quick answer
Rosuvastatin (5mg，10mg，20mg) for Carotid Atherosclerosis is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Carotid Atherosclerosis
- Phase
- Approved
- Modality
- small_molecule
- Status
- active